MELBOURNE, Australia and INDIANAPOLIS, Oct. 23, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that it has dosed the first patient in a Phase 1 ...

Viking Therapeutics, Inc. ( NASDAQ: VKTX) Q3 2025 Earnings Call October 22, 2025 4:30 PM EDT Welcome to the Viking Therapeutics Third Quarter 2025 Financial Results Conference Call. [Operator ...

PRAME cell therapy in 16 patients with metastatic uveal melanoma in the ongoing Phase 1b trial continues to show strong ...

Encouraging preliminary activity observed across diverse set of advanced ALK-positive solid tumors Global enrollment ongoing for adult and adolescent ...

Swiss biotech Oculis is poised to start registration trials for privosegtor, its drug candidate for neuro-ophthalmic diseases, in the wake of encouraging phase 2 data. The Zug-based company said ...

Minerva secures $80 million up front and up to an additional $80 million subject to the full exercise of Tranche A warrants.Minerva and the FDA have defined a path forward for roluperidone's clinical ...

Acquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed high treatment response ICT01 has the potential to be a ...

Explore 10 fun competitive dog sports to keep your pup active and engaged. From agility to dog surfing, boost your dog's skills and have fun.

Kezar Life Sciences (KZR) announced regulatory updates and the initiation of a process to explore a full range of strategic alternatives focused ...

A court in Ivory Coast has sentenced 26 opposition protesters to 36 months in prison, a lawyer for the opposition party said Friday. The protesters were part of a large ...

RAD has received firm commitments for a A$35 million capital raising via an institutional private placement to new Australian and international institutional and sophisticated investors at A$0.03 per ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ TORONTO, Oct. 16, 2025 /CNW/ – TERAGO Inc. (“TERAGO” or the “Company”) (TSX: TGO), ...